CLINICAL_TRIALS
research
· 2026-04-02
Clinical Trial Update: A Study Evaluating TRIV-509 in Atopic Dermatitis [Phase 2]
Summary
This clinical trial update reports a Phase 2 study evaluating TRIV-509 for atopic dermatitis, which is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Triveni Bio | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING